In-Hospital Mortality of COVID-19 Patients Treated with High-Flow Nasal Oxygen: Evaluation of Biomarkers and Development of the Novel Risk Score Model CROW-65

In-Hospital Mortality of COVID-19 Patients Treated with High-Flow Nasal Oxygen: Evaluation of Biomarkers and Development of the Novel Risk Score Model CROW-65

To replace mechanical ventilation (MV), which represents the cornerstone therapy in severe COVID-19 cases, high-flow nasal oxygen (HFNO) therapy has recently emerged as a less-invasive therapeutic possibility for those patients. Respecting the risk of MV delay as a result of HFNO use, we aimed to ev...

Full description

Bibliographic Details
Main Authors: Toni Kljakovic Gaspic, Mirela Pavicic Ivelja, Marko Kumric, Andrija Matetic, Nikola Delic, Ivana Vrkic, Josko Bozic
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Life
Subjects:
COVID-19
HFNO
in-hospital outcomes
mechanical ventilation
risk scores
Online Access:https://www.mdpi.com/2075-1729/11/8/735

Internet

https://www.mdpi.com/2075-1729/11/8/735

Similar Items